Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DOCK9 antibody (AA 1250-1300)

The Rabbit Polyclonal anti-DOCK9 antibody has been validated for IP. It is suitable to detect DOCK9 in samples from Human.
Catalog No. ABIN7452311

Quick Overview for DOCK9 antibody (AA 1250-1300) (ABIN7452311)

Target

See all DOCK9 Antibodies
DOCK9 (Dedicator of Cytokinesis 9 (DOCK9))

Reactivity

  • 14
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 16
Rabbit

Clonality

  • 16
Polyclonal

Conjugate

  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DOCK9 antibody is un-conjugated

Application

  • 8
  • 5
  • 4
  • 2
  • 2
  • 2
Immunoprecipitation (IP)
  • Binding Specificity

    • 2
    • 1
    • 1
    • 1
    • 1
    AA 1250-1300

    Purpose

    Rabbit anti-DOCK9 Antibody, Affinity Purified

    Purification

    Affinity Purified

    Immunogen

    between AA 1250 and 1300

    Isotype

    IgG
  • Application Notes

    IP: 2 - 5 μg/mg lysate

    WB: Not recommended. Use rabbit anti-DOCK9 antibody ABIN7452204 or ABIN7450988.

    Restrictions

    For Research Use only
  • Concentration

    1000 μg/mL

    Buffer

    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Expiry Date

    12 months
  • Target

    DOCK9 (Dedicator of Cytokinesis 9 (DOCK9))

    Alternative Name

    DOCK9

    Background

    Background: Dedicator of cytokinesis 9 (DOCK9) is a Rho-GTPase guanine-nucleotide exchange factor (GEF) that activates Rho by catalyzing the exchange of GDP for GTP. DOCK9 is responsible for activating Cdc42, a Rho family GTPase that is involved in cell polarity, gene expression, cell-cycle progression and cell-cell interactions.

    Gene ID

    23348

    NCBI Accession

    NP_056111

    UniProt

    Q9BZ29
You are here:
Chat with us!